US2016100A
(en)
|
1932-01-06 |
1935-10-01 |
Schwarzkopf Erich |
Thermo-magnetically actuated source of power
|
US2015101A
(en)
|
1933-08-16 |
1935-09-24 |
Edna W Dieckmann |
Terminal fixture aperture indicator
|
US2016103A
(en)
|
1933-09-01 |
1935-10-01 |
Hugo J Chott |
Dental aligning and testing device
|
US2016101A
(en)
|
1934-03-26 |
1935-10-01 |
Charles A Towne |
Apparatus for drawing tabs from addressograph plate carriers
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
US5837249A
(en)
|
1985-04-19 |
1998-11-17 |
The Wistar Institute |
Method for generating an immunogenic T cell response protective against a virus
|
US5726288A
(en)
|
1989-11-13 |
1998-03-10 |
Massachusetts Institute Of Technology |
Localization and characterization of the Wilms' tumor gene
|
US5229115A
(en)
|
1990-07-26 |
1993-07-20 |
Immunex Corporation |
Adoptive immunotherapy with interleukin-7
|
EP0573608A1
(en)
|
1991-02-07 |
1993-12-15 |
Molecumetics, Ltd. |
Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
|
AU6363094A
(en)
|
1993-03-15 |
1994-10-11 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Peptide coated dendritic cells as immunogens
|
WO1995029240A1
(en)
|
1994-04-22 |
1995-11-02 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines
|
US5622835A
(en)
|
1994-04-28 |
1997-04-22 |
The Wistar Institute Of Anatomy & Biology |
WT1 monoclonal antibodies
|
US5643786A
(en)
|
1995-01-27 |
1997-07-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for isolating dendritic cells
|
US6156316A
(en)
|
1995-05-08 |
2000-12-05 |
Sloan-Kettering Institute For Cancer Research |
Oncogene fusion protein peptide vaccines
|
JPH11171896A
(ja)
|
1995-09-19 |
1999-06-29 |
Kirin Brewery Co Ltd |
新規ペプチド化合物およびその医薬組成物
|
US5981217A
(en)
|
1995-12-11 |
1999-11-09 |
Mayo Foundation For Medical Education And Research |
DNA encoding TGF-β inducible early factor-1 (TIEF-1), a gene expressed by osteoblasts
|
ATE244300T1
(de)
|
1996-01-17 |
2003-07-15 |
Imp College Innovations Ltd |
Immunotherapie mit verwendung von zytotoxischen t lymphozyten (ctl)
|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
US6207375B1
(en)
|
1996-12-11 |
2001-03-27 |
Mayo Foundation For Medical Educational & Research |
TGF-β inducible early factor-1 (TIEF-1) and a method to detect breast cancer
|
ID27813A
(id)
|
1998-01-28 |
2001-04-26 |
Corixa Corp |
Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
|
JP4422903B2
(ja)
|
1998-07-31 |
2010-03-03 |
株式会社癌免疫研究所 |
癌抑制遺伝子wt1の産物に基づく癌抗原
|
US20030072767A1
(en)
|
1998-09-30 |
2003-04-17 |
Alexander Gaiger |
Compositions and methods for WT1 specific immunotherapy
|
US7655249B2
(en)
|
1998-09-30 |
2010-02-02 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7115272B1
(en)
|
1998-09-30 |
2006-10-03 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7901693B2
(en)
|
1998-09-30 |
2011-03-08 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7144581B2
(en)
|
2000-10-09 |
2006-12-05 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7063854B1
(en)
|
1998-09-30 |
2006-06-20 |
Corixa Corporation |
Composition and methods for WTI specific immunotherapy
|
US20120301492A1
(en)
|
1998-09-30 |
2012-11-29 |
Corixa Corporation |
Compositions and methods for wt1 specific immunotherapy
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7329410B1
(en)
|
1998-09-30 |
2008-02-12 |
Corixa Corporation |
Compositions and method for WT1 specific immunotherapy
|
GB9823897D0
(en)
|
1998-11-02 |
1998-12-30 |
Imp College Innovations Ltd |
Immunotherapeutic methods and molecules
|
EP1144444A3
(en)
|
1998-12-22 |
2002-01-02 |
Genset |
Dnas encoding proteins with signal sequences
|
AU3395900A
(en)
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
Human lung cancer associated gene sequences and polypeptides
|
CA2367692A1
(en)
|
1999-03-15 |
2000-09-21 |
Introgen Therapeutics, Inc. |
Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
|
US6593299B1
(en)
|
1999-04-21 |
2003-07-15 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for controlling pests
|
AU7859900A
(en)
|
1999-10-04 |
2001-05-10 |
Corixa Corporation |
Compositions and methods for wt1 specific immunotherapy
|
US20030082194A1
(en)
|
2000-02-22 |
2003-05-01 |
Alexander Gaiger |
Compositions and methods for diagnosis and therapy of malignant mesothelioma
|
NZ521430A
(en)
|
2000-02-22 |
2004-04-30 |
Corixa Corp |
Compositions comprising 1-4 antigenic peptide fragments of the Wilms' tumour gene product for treatment or prevention of malignant mesothelioma
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US6861234B1
(en)
|
2000-04-28 |
2005-03-01 |
Mannkind Corporation |
Method of epitope discovery
|
EP1209226A3
(en)
|
2000-11-07 |
2002-06-05 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70)
|
ATE383375T1
(de)
*
|
2001-03-22 |
2008-01-15 |
Int Inst Cancer Immunology Inc |
Wti-modifiziertes peptid
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
EP1410804A4
(en)
|
2001-06-29 |
2007-10-24 |
Chugai Pharmaceutical Co Ltd |
CANCER VACCINE WITH CANCER ANTIGENS BASED ON TUMOR SUPPRESSOR GEN WT1 PRODUCT AND CATIONIC LIPOSOME
|
US7553494B2
(en)
|
2001-08-24 |
2009-06-30 |
Corixa Corporation |
WT1 fusion proteins
|
WO2003028758A1
(fr)
|
2001-09-28 |
2003-04-10 |
Haruo Sugiyama |
Nouvelle methode d'induction de lymphocytes t specifiques d'un antigene
|
JP5230891B2
(ja)
|
2001-09-28 |
2013-07-10 |
株式会社癌免疫研究所 |
抗原特異的t細胞の新規な誘導方法
|
US20030072761A1
(en)
|
2001-10-16 |
2003-04-17 |
Lebowitz Jonathan |
Methods and compositions for targeting proteins across the blood brain barrier
|
US20030175272A1
(en)
|
2002-03-07 |
2003-09-18 |
Medcell Biologics, Inc. |
Re-activated T-cells for adoptive immunotherapy
|
AU2003242305A1
(en)
*
|
2002-06-12 |
2003-12-31 |
Chugai Seiyaku Kabushiki Kaisha |
Hla-a24-restricted cancer antigen peptide
|
KR101173871B1
(ko)
|
2003-02-06 |
2012-08-16 |
앤저 테라퓨틱스 인코퍼레이티드 |
변형된 독립생존 미생물, 백신 조성물 및 그것의 사용방법
|
US20050008618A1
(en)
|
2003-02-27 |
2005-01-13 |
Howard Kaufman |
Composition for delivering an agent to a target cell and uses thereof
|
EP1601684B1
(en)
|
2003-03-05 |
2014-10-15 |
Dendreon Corporation |
Alternative reading frame polypeptides for treatment
|
EP2343083B1
(en)
|
2003-06-27 |
2014-01-15 |
International Institute of Cancer Immunology, Inc. |
Method of diagnosing cancer comprising the measurement of WT1-specific CTL precursor cells
|
US20050147621A1
(en)
|
2003-10-10 |
2005-07-07 |
Higgins Darren E. |
Use of bacterial 5' untranslated regions for nucleic acid expression
|
CN100513563C
(zh)
*
|
2003-11-05 |
2009-07-15 |
株式会社国际癌症免疫研究所 |
Wt1衍生的hla-dr-结合抗原肽
|
US7488718B2
(en)
|
2003-12-01 |
2009-02-10 |
Sloan Kettering Institue For Cancer Research |
Synthetic HLA binding peptide analogues and uses thereof
|
ES2324538T3
(es)
|
2003-12-05 |
2009-08-10 |
Multimmune Gmbh |
Anticuerpos anti-hsp terapeuticos y de diagnostico.
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
EP1720565A1
(en)
|
2004-03-04 |
2006-11-15 |
Corixa Corporation |
Co-encapsulated wt1 polypeptide and immunostimulant microsphere formulations and methods thereof
|
US20050214268A1
(en)
|
2004-03-25 |
2005-09-29 |
Cavanagh William A Iii |
Methods for treating tumors and cancerous tissues
|
US20050221481A1
(en)
|
2004-03-30 |
2005-10-06 |
Istituto Superiore Di Sanita' |
Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2
|
ES2341785T3
(es)
|
2004-03-31 |
2010-06-28 |
International Institute Of Cancer Immunology, Inc. |
Peptidos antigenicos del cancer derivados de wt1.
|
US9629927B2
(en)
|
2005-07-29 |
2017-04-25 |
Sloan-Kettering Institute For Cancer Research |
Single wall nanotube constructs and uses thereof
|
EP1951281B1
(en)
|
2005-10-17 |
2015-04-15 |
Sloan Kettering Institute For Cancer Research |
Wt1 hla class ii-binding peptides and compositions and methods comprising same
|
ES2352855T3
(es)
|
2005-11-30 |
2011-02-23 |
International Institute Of Cancer Immunology, Inc. |
Nuevos compuestos peptídicos del tumor de wilms.
|
AU2007218649B2
(en)
|
2006-02-22 |
2013-01-10 |
International Institute Of Cancer Immunology, Inc. |
HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
|
ES2387999T3
(es)
|
2006-03-29 |
2012-10-05 |
International Institute Of Cancer Immunology, Inc. |
ARNsi específico de la isoforma WT1 17AA(-) y uso del mismo
|
US9265816B2
(en)
|
2006-04-10 |
2016-02-23 |
Sloan Kettering Institute For Cancer Research |
Immunogenic WT-1 peptides and methods of use thereof
|
WO2007120603A2
(en)
|
2006-04-10 |
2007-10-25 |
Sloan Kettering Institute For Cancer Research |
Immunogenic bcr-abl peptides and methods of use thereof
|
EP2133365B1
(en)
|
2006-12-27 |
2017-05-17 |
Emory University |
Compositions and methods for the treatment of infections and tumors
|
DK2479275T3
(en)
|
2006-12-28 |
2015-12-14 |
Int Inst Cancer Immunology Inc |
HLA-A * 1101-restricted WT1 peptide or pharmaceutical composition comprising this
|
KR101323540B1
(ko)
|
2007-02-07 |
2013-10-29 |
사이단호진한다이비세이부쯔뵤우겐큐우카이 |
암의 치료제
|
MX352947B
(es)
|
2007-02-27 |
2017-12-14 |
Int Inst Cancer Immunology Inc |
Metodo para activacion de celula t auxiliar y composicion para usarse en el metodo.
|
US20090035360A1
(en)
|
2007-05-24 |
2009-02-05 |
Dominique Ingrid Lemoine |
Lyophilised antigen composition
|
KR100995340B1
(ko)
|
2007-11-19 |
2010-11-19 |
재단법인서울대학교산학협력재단 |
자연 살해 t 세포의 리간드와 항원을 적재한 단핵구 또는미분화 골수성 세포를 포함하는 백신
|
ES2679127T3
(es)
|
2007-12-05 |
2018-08-22 |
International Institute Of Cancer Immunology, Inc. |
Composición vacunal contra el cáncer
|
KR100900837B1
(ko)
|
2007-12-07 |
2009-06-04 |
(주)두비엘 |
리포펩타이드와 폴리(i:c)를 아쥬반트로 포함하는 강력한백신 조성물
|
CA2724649A1
(en)
|
2008-05-19 |
2009-11-26 |
Anza Therapeutics, Inc. |
Compositions comprising prfa* mutant listeria and methods of use thereof
|
WO2010037395A2
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
AR076349A1
(es)
|
2009-04-23 |
2011-06-01 |
Int Inst Cancer Immunology Inc |
Peptido auxiliar del antigeno del cancer
|
WO2011059835A2
(en)
|
2009-11-11 |
2011-05-19 |
Quest Diagnostics Investments Incorporated |
Wt1 mutations for prognosis of myeloproliferative disorders
|
US20110136141A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
WO2011100754A1
(en)
|
2010-02-15 |
2011-08-18 |
The Trustees Of The University Of Pennsylvania |
Live listeria-based vaccines for central nervous system therapy
|
SG10201508252PA
(en)
|
2010-10-05 |
2015-11-27 |
Int Inst Cancer Immunology Inc |
Method for activating helper t cell
|
AP2013007158A0
(en)
|
2011-03-11 |
2013-10-31 |
Gilead Calistoga Llc |
Combination therapies for hematologic malignancies
|
KR20140039318A
(ko)
|
2011-06-28 |
2014-04-01 |
인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 |
펩티드 암 항원 특이적 t 세포의 리셉터 유전자
|
AU2012291101B2
(en)
|
2011-07-29 |
2016-04-07 |
Riken |
Cell for use in immunotherapy which contains modified nucleic acid construct encoding Wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct
|
US9539299B2
(en)
|
2011-10-27 |
2017-01-10 |
International Institute Of Cancer Immunology, Inc. |
Combination therapy with WT1 peptide vaccine and temozolomide
|
JP6218175B2
(ja)
|
2011-12-14 |
2017-10-25 |
国立大学法人高知大学 |
ヘルパーt細胞誘導性ポリペプチドの改変
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
CN104395462B
(zh)
|
2012-05-03 |
2017-09-26 |
弗雷德哈钦森癌症研究中心 |
增强亲和力的t细胞受体及其制备方法
|
CN109106945B
(zh)
|
2012-10-23 |
2023-04-18 |
优比维克有限责任公司 |
用于治疗疾病的同种异体自噬体富集组合物
|
SG10201705028WA
(en)
|
2012-12-17 |
2017-07-28 |
Otsuka Pharma Co Ltd |
Method for activating helper t cell
|
US9695444B2
(en)
|
2012-12-26 |
2017-07-04 |
BioComo Inc. |
Vaccine prepared utilizing human parainfluenza virus type 2 vector
|
HUE052541T2
(hu)
|
2013-01-15 |
2021-05-28 |
Memorial Sloan Kettering Cancer Center |
Immunogén WT-1 peptidek és eljárások azok alkalmazására
|
US10071051B2
(en)
|
2013-02-05 |
2018-09-11 |
Nitto Denko Corporation |
WT1 peptide cancer vaccine composition for transdermal administration
|
RU2697443C2
(ru)
|
2013-02-05 |
2019-08-14 |
Нитто Денко Корпорейшн |
Препарат противораковой вакцины, содержащий пептид wt1, в форме ленты трансдермального введения
|
KR102045029B1
(ko)
|
2013-02-05 |
2019-11-14 |
닛토덴코 가부시키가이샤 |
점막 투여용 wt1 펩티드 암 백신 조성물
|
CA2841016A1
(en)
|
2013-02-05 |
2014-08-05 |
Nitto Denko Corporation |
Wt1 peptide cancer vaccine composition for transdermal administration
|
EP2956544B1
(en)
|
2013-02-14 |
2017-11-01 |
Immunocellular Therapeutics Ltd. |
Cancer vaccines and vaccination methods
|
CN105142656B
(zh)
|
2013-03-12 |
2019-05-10 |
大日本住友制药株式会社 |
水性液体组合物
|
EP2968607B1
(en)
|
2013-03-15 |
2019-07-24 |
The Trustees Of The University Of Pennsylvania |
Cancer vaccines and methods of treatment using the same
|
ES2691091T3
(es)
|
2013-03-29 |
2018-11-23 |
Sumitomo Dainippon Pharma Co., Ltd. |
Vacuna conjugada de péptido antigénico de WT1
|
PL2988762T3
(pl)
|
2013-04-25 |
2019-01-31 |
Vaximm Ag |
Wektory na bazie Salmonella do immunoterapii przeciwnowotworowej ukierunkowanej na gen guza Wilmsa WT1
|
EP2998740B1
(en)
|
2013-05-13 |
2023-07-05 |
International Institute of Cancer Immunology, Inc. |
Method for predicting clinical effect of immunotherapy
|
US10898555B2
(en)
|
2013-07-02 |
2021-01-26 |
Japanese Foundation For Cancer Research |
Cellular immunity inducing vaccine
|
CN105873945B
(zh)
|
2013-11-22 |
2020-07-17 |
伊利诺伊州大学理事会 |
工程化的高亲和力人类t细胞受体
|
DK3082850T3
(da)
|
2013-12-18 |
2019-10-07 |
Vaximm Gmbh |
Msln-targeteret dna-vaccine til cancerimmunterapi
|
US10835595B2
(en)
|
2014-01-06 |
2020-11-17 |
The Trustees Of The University Of Pennsylvania |
PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy
|
US10253075B2
(en)
|
2014-02-26 |
2019-04-09 |
tella, Inc. |
WT1 antigenic polypeptide, and anti-tumor agent containing said polypeptide
|
US10023841B2
(en)
|
2014-05-23 |
2018-07-17 |
Baylor Research Institute |
Methods and compositions for treating breast cancer with dendritic cell vaccines
|
US10525096B2
(en)
|
2014-12-11 |
2020-01-07 |
International Institute Of Cancer Immunology, Inc. |
Immunotherapy for angiogenic disease
|
JP6770269B2
(ja)
|
2015-06-25 |
2020-10-14 |
国立大学法人神戸大学 |
経口腫瘍ワクチン
|
US20190054112A1
(en)
|
2015-09-18 |
2019-02-21 |
Moderna Therapeutics, Inc. |
Polynucleotide formulations for use in the treatment of renal diseases
|